Enovix Corporation (ENVX) AI Stock Analysis
ENVX AI stock analysis summary
AI ResearchEnovix Corporation designs and manufactures advanced lithium-ion batteries for consumer electronics, industrial applications, and electric vehicles. In FY2025, the company generated revenue of $31.8M but recorded a net income of -$156.7M and negative free cash flow of -$113.5M. As of June 30, 2026, Enovix maintained $475.8M in cash and short-term investments alongside total debt of $537.5M.
- Market cap
- $546.4M
- Revenue (TTM)
- $35.9M
- P/E
- —
- 1Y return
- -78.4% S&P 500 16.8%
- Avg. target
- $9.75 291.6% vs last close
Bull case
- Analysts forecast revenue to increase 93.7% in the next fiscal year to reach $75.7M.
- The balance sheet maintains substantial liquidity, with $475.8M in cash and short-term investments and a current ratio of 9.71 as of June 30, 2026.
- The consensus analyst price target of $9.75 represents 291.6% upside compared to the last close of $2.49.
Bear case
- Enovix continues to burn capital, generating operating cash flow of -$95.3M and free cash flow of -$113.5M in FY2025.
- The company remains unprofitable, recording an operating margin of -479.8% over the trailing twelve months and net income of -$156.7M in FY2025.
- Valuation multiples remain elevated, with price-to-sales at 15.2x compared to the 1.5x median for US-listed Industrials peers.
What Enovix does
Enovix Corporation specializes in the design, development, and manufacturing of advanced lithium-ion batteries. Engineered for high performance and reliability, its batteries serve diverse industries including wearables and IoT devices, smartphones, laptops, tablets, industrial applications, medical equipment, and electric vehicles. Founded in 2007 and based in Fremont, California, the company operates from Silicon Valley to leverage local technological infrastructure and research talent. Enovix utilizes specialized manufacturing facilities adhering to quality standards and collaborates with commercial partners to develop customized energy solutions that optimize performance and efficiency.
Growth and profitability
Annual revenue grew from $120 in FY2021 to $6.2M in FY2022, dropped to $263,000 in FY2023, and subsequently expanded to $23.1M in FY2024 and $31.8M in FY2025, representing a 4-year revenue CAGR of 2169.3%. Profitability metrics remained negative across this period, with FY2025 gross margin at -86.8%, operating margin at -554.8%, and net income of -$156.7M, while research and development expense stood at $110.3M. For the trailing twelve months ending June 30, 2026, revenue totaled $35.9M with an operating margin of -479.8% and EPS of -$0.80. In the latest quarter ending June 30, 2026, quarterly revenue grew 20.8% year-over-year.
Balance sheet and cash flow
As of June 30, 2026, Enovix held $475.8M in cash and short-term investments against total debt of $537.5M, resulting in net debt of $61.7M. Total assets stood at $799.6M and shareholders' equity was $209.9M, supporting a current ratio of 9.71 and a debt-to-equity ratio of 2.56. During FY2025, the company used cash for operations, recording operating cash flow of -$95.3M and free cash flow of -$113.5M. Cash deployment included capital expenditures of $18.2M and share buybacks of $58.4M, while the share count rose 54.8% over five years.
Valuation and performance
Enovix trades at a price-to-sales multiple of 15.2x and an EV to revenue multiple of 19.7x, both above the median of its US-listed Industrials peers, which trade at a median price-to-sales multiple of 1.5x. The company carries a price-to-book ratio of 3.1x, with a market capitalization of $546.4M and an enterprise value of $708.0M. Over the past year, the stock fell 78.4%, while the S&P 500 returned 16.8%. Over a 5-year period, the stock declined 88.1% compared to an 83.0% return for the benchmark index.
What analysts expect
Wall Street analysts hold 8 Strong Buy, 0 Buy, 3 Hold, 1 Sell, and 0 Strong Sell ratings on the stock. The mean price target is $9.75, which stands 291.6% above the last closing price of $2.49. For the fiscal year ending December 31, 2026, the consensus EPS estimate is -$0.55 on revenue of $39.1M. Looking ahead to the next fiscal year, 10 analysts project revenue of $75.7M, indicating expected revenue growth of 93.7%. Enovix beat EPS estimates in each of the last 4 quarters, and its next earnings date is November 4, 2026.
Key risks and what to watch
- Total debt of $537.5M exceeds cash reserves, creating net debt of $61.7M and a debt-to-equity ratio of 2.56.
- The stock has an elevated short interest level, with short percent of float at 27.1%.
- Shareholder dilution has been substantial, with the 5-year share count increasing 54.8%.
- High equity volatility is reflected in the stock's beta of 2.48.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this ENVX AI stock analysis
This page is an AI-written research summary of Enovix Corporation (ENVX). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: ENVX income statement, ENVX balance sheet, ENVX key metrics, ENVX analyst forecast, ENVX chart. See the ENVX stock overview for the latest quote and news.
ENVX AI stock analysis FAQ
Does Enovix Corporation pay a dividend?
Enovix Corporation does not pay a dividend. In FY2025, cash capital allocation was directed toward $18.2M in capital expenditures and $58.4M in share buybacks.
What is the consensus analyst target for ENVX stock?
The mean analyst price target is $9.75, which is 291.6% higher than the last closing price of $2.49.
How much cash and debt does Enovix have?
As of June 30, 2026, Enovix held $475.8M in cash and short-term investments alongside total debt of $537.5M, resulting in net debt of $61.7M.
What are analysts projecting for Enovix's upcoming revenue?
Analysts estimate current fiscal year revenue of $39.1M ending December 31, 2026, followed by $75.7M in the next fiscal year, representing expected growth of 93.7%.